Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age50-90
SponsorHoffmann-La Roche

About this trial

This study is a pre-screening process used to assess participants' potential eligibility for Roche interventional Alzheimer's disease studies.

Eligibility criteria

Qualifiers

None

Disqualifiers

Dependency in basic activities of daily living (bADLs) due to cognitive impairment

Visual or auditory impairment that would prevent them from performing the cognitive assessments (eyeglasses and hearing aids are permitted)

Any self-reported evidence or known diagnosis of a neurological or neurodegenerative condition that may lead to cognitive impairment other than AD

History of severe, clinically significant central nervous system trauma

Trial design

Treatments tested in this trial

  • No Intervention

Treatment groups

13,000 Participants
are divided into 1 treatment group

Sponsors and collaborators